Eliem Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Eliem Therapeutics generated cash of -$20,599,000, which is more than the previous year. Cash used in financing activities reached the amount of $841,000 last year. Net change in cash is therefore $49,527,000.
Cash Flow
| 2019 | -5.00M | 0 | 26.24M |
|---|---|---|---|
| 2020 | -14.09M | 8.07M | 4.92M |
| 2021 | -36.07M | -114.97M | 177.23M |
| 2022 | -37.36M | 34.44M | 0 |
| 2023 | -20.59M | 68.98M | 841K |
ELYM Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 43.58M | 46.92M | 20.48M | 21.22M | 0 |
Operating activities | |||||
Net income | -35.11M | -45.24M | -47.48M | -20.66M | -6.54M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 0 | 0 | 1.84M | 0 | 0 |
Stock-based compensation expense | 12.80M | 6.99M | 3.73M | 707K | 0 |
| Deferred income tax benefit | 12.80M | 6.99M | 3.73M | 707K | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -686K | -653K | 150K | -24K | 17K |
Cash generated by operating activities | -20.59M | -37.36M | -36.07M | -14.09M | -5.00M |
Investing activities | |||||
Purchases Of Investments | -58.44M | -87.96M | -114.97M | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 8.27K | 0 |
Cash generated by investing activities | 68.98M | 34.44M | -114.97M | 8.07M | 0 |
Financing activities | |||||
Common Stock Issued | 841K | 0 | 83.14M | 4.92M | 26.24M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 841K | 0 | 177.23M | 4.92M | 26.24M |
Net Change In Cash | 49.52M | -3.33M | 26.43M | -736K | 21.22M |
Cash at end of period | 93.11M | 43.58M | 46.92M | 20.48M | 21.22M |
| Data source | Data source | Data source |